Cell-based tissue engineering therapies: The influence of whole body physiology

Advanced Drug Delivery Reviews

Volumn 33, Issue 1-2, 1998, Pages 3-14

  Haynesworth, Stephen E ^a   Reuben, Daniel ^a   Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Bone resorption; Cytokines; Hematopoiesis; Mesenchymal stem cell; Mesengenesis; Osteoporosis

Indexed keywords

CELL CULTURE; CYTOLOGY; DISEASES; PHYSIOLOGY; TISSUE CULTURE;

BONE REGENERATION; OSTEOPOROSIS;

BONE;

CYTOKINE;

BIOMEDICAL ENGINEERING; BONE MARROW; HEMATOPOIESIS; HUMAN; MESENCHYME; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; TISSUE REPAIR;

EID: 0032479799     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00016-7     Document Type: Review

References (46)

1. [1] H. Fleisch, Physiology, in: Bisphosphonates in Bone Disease; From the Laboratory to the Patient, third ed., Parthenon, 1997, p. 20.
2. [2] S.E. Haynesworth, J. Goshima, V.M. Goldberg, A.I. Caplan, Characterization of cells with osteogenic potential from human marrow, Bone 13 (1992) 81-88.
3. [3] S.E. Haynesworth, M.A. Baber, A.I. Caplan, Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1α, J. Cell. Physiol. 166 (1996) 585-592.
4. [4] N. Jaiswal, S.E. Haynesworth, A.I. Caplan, S.P. Bruder, Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro, J. Cell. Biochem. 64 (1997) 295-312.
5. [5] S.P. Bruder, N. Jaiswal, S.E. Haynesworth, Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation, J. Cell. Biochem. 64 (1997) 278-294.
6. [6] L. Malaval, D. Modrowski, A.K. Gupta, J.E. Aubin, Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures, J. Cell. Physiol. 158(3) (1994) 555-572.
7. [7] R.M. Locklin, M.C. Williamson, J.N. Beresford, J.T. Triffitt, M.E. Owen, In vitro effects of growth factors and dexamethasone on rat marrow stromal cells, Clin. Orthop. Relat. Res. 313 (1995) 27-35.
8. [8] D.J. Rickard, T.A. Sullivan, B.J. Shenker, P.S. Leboy, I. Kazhdan, Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2, Dev. Biol. 161(1) (1994) 218-228.
9. [9] S. Gronthos, P.J. Simmons, The biology and application of human bone marrow stromal cell precursors, J. Hematother. 5(1) (1996) 15-23.
10. [10] S.A. Kuznetsov, A.J. Friedenstein, P.G. Robey, Factors required for bone marrow stromal fibroblast colony formation in vitro, Br. J. Haematol. 97(3) (1997) 561-570.
11. [11] S.L. Cheng, J.W. Yang, L. Rifas, S.F. Zhang, L.V. Avioli, Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone, Endocrinology 134(1) (1994) 277-286.
12. [12] A.Y. Friedenstein, Precursor cells of mechanocytes, Int. Rev. Cytol. 47 (1970) 327-355.
13. [13] M. Owen, Marrow stromal stem cells, J. Cell Sci. Suppl. 10 (1988) 1063-1076.
14. [14] M. Owen, The origin of bone cells in the postnatal organism, Arthritis Rheum. 23(10) (1980) 1073-1078.
15. [15] I. Bab, B. Ashton, D. Gazit, et al., Osteogensis in in vivo diffusion chambers cultures of human marrow cells, Bone Miner. 4 (1988) 373-386.
16. [16] I. Bab, C. Howlett, B. Ashton, M. Owen, Ultrastructure of bone and cartilage formed in vivo in diffusion chambers, Clin. Orthop. 187 (1984) 243-254.
17. [17] B. Ashton, T. Allen, C. Howlett, C. Eaglesom, A. Hattori, M. Owen, Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo, Clin. Orthop. 151 (1980) 294-307.
18. [18] B. Ashurst, C. Eaglesom, I. Bab, M. Owen, Bone marrow stromal cells raised in diffusion chambers produce typical bone and cartilage matrices, Calcif. Tissue Int. 42(Suppl.) (1988) 2.
19. [19] S.L. Gerson, P.L. Page, B. Hartwell, S.H. Robinson, Altered growth characteristics of murine hematopoietic cells induced by cytotoxic drugs, Stem Cells 2 (1983) 266-279.
20. [20] D. Gazit, M. Karmish, L. Holzman, I. Bab, Regenerating marrow induces systemic increase in osteo- and chondrogenesis, Endocrinology 126(5) (1990) 2607-2613.
21. [21] J. Foldes, E. Naparstek, M. Statter, J. Menczel, I. Bab, Osteogenic response to marrow aspiration: increased serum osteocalcin and alkaline phosphatase in human bone marrow donors, Bone Miner. Res. 4(4) (1989) 643-646.
22. [22] Z. Greenberg, M. Chorev, A. Muhlrad, et al., Structural and functional characterization of osteogenic growth peptide from human serum: identity with rat and mouse homologs, J. Clin. Endocrinol. Metab. 80(8) (1995) 2330-2335.
23. [23] S.E. Haynesworth, M.A. Baber, A.I. Caplan, Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies, Bone 13 (1992) 69-80.
24. [24] S.P. Bruder, M.C. Horowitz, S.E. Haynesworth, Monoclonal antibodies selective for human osteogenic cell surface antigens, Bone 21(2) (1997) 225-235.
25. [25] S.E. Haynesworth, B.A. Baber, A.I. Caplan, Characterization of the unique mesenchymal stem cell phenotype in vitro, Transactions of the 41st Annual Meeting Orthopaedic Research Society 20 (1) (1995) 7.
26. [26] D.P. Lennon, S.E. Haynesworth, S.P. Bruder, N. Jaiswal, A.I. Caplan, Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation, In Vitro 32 (1996) 602-611.
27. [27] B. Johnstone, J. Yoo, F. Barry, In vitro chondrogenesis of bone marrow-derived mesenchymal cells, Trans. Orthop. Res. Soc. 21 (1996) 65.
28. [28] M.P. Majumdar, S.E. Haynesworth, M.A. Theide, D.R. Marshak, A.I. Caplan, S.L. Gerson, Culture-expanded human mesenchymal stem cells (MSCs) express cytokines and support hematopoiesis in vitro, Blood 86 (1995) 494A.
29. [29] M.F. Pittenger, A. Mackay, S. Beck, Human mesenchymal stem cells can be directed into chondrocytes adipocytes or osteocytes, Mol. Biol. Cell. 7 (1996) in press.
30. [30] S. Wakitani, T. Saito, A. Caplan, Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine, Muscle Nerve 18 (1995) 1417-1426.
31. [31] A.I. Caplan, D.J. Fink, T. Goto, A.E. Linton, R.G. Young, S. Wakitani, V.M. Goldberg, S.E. Haynesworth, Mesenchymal stem cells and tissue repair, in: D. Jackson, S. Arnocsky, S. Woo, C. Frank (Eds.), The Anterior Cruciate Ligament: Current and Future Concepts, Raven Press, New York, 1993, pp. 405-417.
32. [32] S.E. Haynesworth, R.G. Young, A.I. Caplan, Comparison of the osteogenic potential of marrow-derived mesenchymal cells from young and old donors, Transactions of the 38th Annual Meeting Orthopaedics Research Society 17 (2) (1992) 600.
33. [33] S.E. Haynesworth, V.M. Goldberg, A.I. Caplan, Diminution of the number of mesenchymal stem cells as a cause for skeletal aging, in: J.A. Buckwalter, V.M. Goldberg, S.L-Y. Woo (Eds.), Musculoskeletal Soft-Tissue Aging: Impact on Mobility, Section 1, Chapter 7, AAOS/NIH Workshop on Aging-Related Changes in the Musculoskeletal Soft Tissue, November 19, 1992, Colorado Springs, Colorado, 1993, pp. 80-86.
34. [34] J.E. Dennis, S.E. Haynesworth, R.G. Young, A.I. Caplan, Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on the cell retention and rate of osteogenic expression, Cell Transplant. 1 (1993) 23-32.
35. [35] J. Dennis, A. Caplan, Porous ceramic vehicles for rat marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin, J Oral Implantol. 19 (1993) 106-115.
36. [36] T. Tsuji, F.J. Hughes, C.A. McCulloch, et al., The effects of donor age on osteogenic cells of rat marrow in vitro, Mech. Ageing Dev. 51 (1990) 121-132.
37. [37] S.A. Dodson, G.W. Bernard, E.B. Kenney, F.A. Carranza, In vitro comparison of aged young osteogenic and hemopoietic bone marrow stem cells and their derivative colonies, J. Periodontol. 67(3) (1996) 184-196.
38. [38] D. Egrise, D. Martin, A. Vienne, P. Neve, A. Schoutens, The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats, Bone 13(5) (1992) 355-361.
39. [39] H. Tanaka, C.T. Liang, Mitogenic activity but not phenotype expression of rat osteoprogenitor cells in response to IGF-I is impaired in aged rats, Mech. Ageing Dev. 92(1) (1996) 1-10.
40. [40] S. Haynesworth, Interleukin-1 modulates glucocorticoid-induced osteogenic differentiation and the expression of bone resorptive cytokines by human mesenchymal stem cells, Nineteenth Annual Meeting of the American Society for Bone and Mineral Research 12(1) (1997) 323.
41. [41] J.A. Allay, J.E. Dennis, S.E. Haynesworth, et al., Retroviral transductions of marrow-derived mesenchymal precursors, Blood 82(1) (1994) 477A.
42. [42] J.A. Allay, J.E. Dennis, S.E. Haynesworth et al. LacZ and IL-3 expression in vivo in retrovirally transduced marrow-derived human osteogenic mesenchymal progenitors, (1997) in press.
43. [43] R. Pereira, K. Halford, M. O'Hara, et al., Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice, Proc. Natl. Acad. Sci. USA 92 (1995) 4857-4861.
44. [44] H. Lazarus, S.E. Haynesworth, N. Rosenthal, S. Gerson, A.I. Caplan, Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal stem cells) [MSCs]: implications for therapeutic use, Bone Marrow Transplant. 16 (1995) 557-564.
45. [45] Q.A. Albakri, S.E. Haynesworth, Human mesenchymal stem cell cultures contain factors with automitogenic activity, Nineteenth Annual Meeting of the American Society for Bone Marrow Research 12(1) (1997) F354.
46. [46] Caplan and Dennis, Mesenchymalstem cells: Progenitors, progeny, and pathways, J Bone Miner. Metab. 14 (1996) 193-201.